• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Medicis recalls certain lots of Solodyn tablets

Article

Scottsdale, Ariz. - Medicis Pharmaceutical has issued a statement announcing its voluntary recall of lot numbers B080037 and B080038 of the antibiotic Solodyn Extended Release Tablets, 90 mg, 30-count bottles, both of which carry an expiration date of December 2009.

Scottsdale, Ariz. - Medicis Pharmaceutical has issued a statement announcing its voluntary recall of lot numbers B080037 and B080038 of the antibiotic Solodyn Extended Release Tablets, 90 mg, 30-count bottles, both of which carry an expiration date of December 2009.

Medicis received a report that one bottle in lot number B080037 contains Azasan azathioprine tablets instead of Solodyn Extended Release Tablets. Azasan is an immunosuppressive agent used in transplant patients to prevent kidney rejection and for the treatment of rheumatoid arthritis.

Taking Azasan instead of Solodyn presents a safety risk to patients; the drug’s potential side effects, particularly in elderly patients, include mylosuppression, infection, bleeding, chills, nausea, vomiting, diarrhea, and joint and muscle pain. Interactions with other drugs may also result in serious adverse events.

Medicis suggests that inquiries related to this recall be addressed to Stericycle Customer Service at (888) 656-6381. For medical information inquiries or to report an adverse event related to the recall, call Medicis at (800) 900-6389.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.